- Home
- EEFT vs BHVN Comparison
EEFT vs BHVN Comparison
Compare EEFT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEFT
- BHVN
- Stock Information
- Founded
- EEFT 1994
- BHVN 2013
- Country
- EEFT United States
- BHVN United States
- Employees
- EEFT N/A
- BHVN N/A
- Industry
- EEFT EDP Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- EEFT Technology
- BHVN Health Care
- Exchange
- EEFT Nasdaq
- BHVN Nasdaq
- Market Cap
- EEFT 4.7B
- BHVN 4.7B
- IPO Year
- EEFT 1997
- BHVN 2017
- Fundamental
- Price
- EEFT $107.60
- BHVN $39.07
- Analyst Decision
- EEFT Buy
- BHVN Strong Buy
- Analyst Count
- EEFT 8
- BHVN 13
- Target Price
- EEFT $128.14
- BHVN $63.00
- AVG Volume (30 Days)
- EEFT 220.1K
- BHVN 887.1K
- Earning Date
- EEFT 02-05-2025
- BHVN 11-12-2024
- Dividend Yield
- EEFT N/A
- BHVN N/A
- EPS Growth
- EEFT 27.95
- BHVN N/A
- EPS
- EEFT 6.88
- BHVN N/A
- Revenue
- EEFT $3,900,200,000.00
- BHVN N/A
- Revenue This Year
- EEFT $10.39
- BHVN N/A
- Revenue Next Year
- EEFT $7.76
- BHVN $197.09
- P/E Ratio
- EEFT $15.45
- BHVN N/A
- Revenue Growth
- EEFT 8.46
- BHVN N/A
- 52 Week Low
- EEFT $91.07
- BHVN $26.80
- 52 Week High
- EEFT $117.66
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- EEFT 65.70
- BHVN 37.27
- Support Level
- EEFT $102.40
- BHVN $36.70
- Resistance Level
- EEFT $107.85
- BHVN $42.13
- Average True Range (ATR)
- EEFT 2.50
- BHVN 2.52
- MACD
- EEFT 0.15
- BHVN -0.39
- Stochastic Oscillator
- EEFT 90.04
- BHVN 25.75
About EEFT Euronet Worldwide Inc.
Euronet Worldwide Inc is a provider of electronic financial transaction solutions. The company operates an independent network of ATMs in Europe, along with a network for prepaid products such as mobile top-ups, and processes point-of-sale transactions. It operates in three segment EFT Processing Segment, epay Segment, and Money Transfer Segment. Its segment revenue comes from by operating income, electronical financial transaction processing, mainly generates revenue from monthly ATM management fees and currency conversion transactions. It generates the majority if its geographic revenue from the United States of America.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.